Literature DB >> 22390151

Th17 cells induce a distinct graft rejection response that does not require IL-17A.

E I Agorogiannis1, F S Regateiro, D Howie, H Waldmann, S P Cobbold.   

Abstract

IL-17A-producing helper T (Th17) cells have been implicated in the pathogenesis of autoimmune disease, inflammatory bowel disease and graft rejection, however the mechanisms by which they cause tissue damage remain ill-defined. We examined what damage Th17 cell lines could inflict on allogeneic skin grafts in the absence of other adaptive lymphocytes. CD4(+) Th17 cell lines were generated from two TCR transgenic mouse strains, A1(M).RAG1(-/-) and Marilyn, each monospecific for the male antigen Dby. After prolonged in vitro culture in polarizing conditions, Th17 lines produced high levels of IL-17A with inherently variable levels of interferon gamma (IFNγ) and these cells were able to maintain IL-17A expression following adoptive transfer into lymphopenic mice. When transferred into lymphopenic recipients of male skin grafts, Th17 lines elicited a damaging reaction within the graft associated with pathological findings of epidermal hyperplasia and neutrophil infiltration. Th17 cells could be found in the grafted skins and spleens of recipients and maintained their polarized phenotype both in vivo and after ex vivo restimulation. Antibody-mediated neutralization of IL-17A or IFNγ did not interfere with Th17-induced pathology, nor did it prevent neutrophil infiltration. In conclusion, tissue damage by Th17 cells does not require IL-17A. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390151     DOI: 10.1111/j.1600-6143.2011.03971.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

Review 1.  Impact of hyperlipidemia on alloimmunity.

Authors:  Jessamyn Bagley; Jin Yuan; John Iacomini
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

2.  Hyperlipidemia Promotes Anti-Donor Th17 Responses That Accelerate Allograft Rejection.

Authors:  J Yuan; J Bagley; J Iacomini
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

3.  IL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts.

Authors:  Pawan Kumar Gupta; Sarah R Wagner; Qiang Wu; Rebecca A Shilling
Journal:  Am J Respir Cell Mol Biol       Date:  2017-06       Impact factor: 6.914

Review 4.  The role of costimulatory molecules in directing the functional differentiation of alloreactive T helper cells.

Authors:  C N Magee; O Boenisch; N Najafian
Journal:  Am J Transplant       Date:  2012-07-03       Impact factor: 8.086

5.  Hyperlipidemia and Allograft Rejection.

Authors:  Jessamyn Bagley; Linus Williams; Michael Hyde; Christian Rosa Birriel; John Iacomini
Journal:  Curr Transplant Rep       Date:  2019-02-26

Review 6.  T Helper Cells Fate Mapping by Co-stimulatory Molecules and its Functions in Allograft Rejection and Tolerance.

Authors:  R Abdoli; N Najafian
Journal:  Int J Organ Transplant Med       Date:  2014

Review 7.  Vascular endothelium as a target of immune response in renal transplant rejection.

Authors:  Giovanni Piotti; Alessandra Palmisano; Umberto Maggiore; Carlo Buzio
Journal:  Front Immunol       Date:  2014-10-21       Impact factor: 7.561

8.  Skin and heart allograft rejection solely by long-lived alloreactive TRM cells in skin of severe combined immunodeficient mice.

Authors:  Qianchuan Tian; Zhaoqi Zhang; Liang Tan; Fan Yang; Yanan Xu; Yinan Guo; Dong Wei; Changhong Wu; Peng Cao; Jiawei Ji; Wei Wang; Xubiao Xie; Yong Zhao
Journal:  Sci Adv       Date:  2022-01-26       Impact factor: 14.136

9.  Foxp3 expression is required for the induction of therapeutic tissue tolerance.

Authors:  Frederico S Regateiro; Ye Chen; Adrian R Kendal; Robert Hilbrands; Elizabeth Adams; Stephen P Cobbold; Jianbo Ma; Kristian G Andersen; Alexander G Betz; Mindy Zhang; Shruti Madhiwalla; Bruce Roberts; Herman Waldmann; Kathleen F Nolan; Duncan Howie
Journal:  J Immunol       Date:  2012-09-17       Impact factor: 5.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.